Skip to Main Content

Author Details

Adrienne Morey
The Canberra Hospital
1987
71
34
PMIDPaper TitleJournal TitlePublished Year
31076089ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia.Pathology2019
31799150Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report.World J Clin Oncol2019
30809956Combined immune therapy grade IV dermatitis in metastatic melanoma.Asia Pac J Clin Oncol2019
31076089ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia.Pathology2019
31106127Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort.Transl Lung Cancer Res2019
31799150Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report.World J Clin Oncol2019
30809956Combined immune therapy grade IV dermatitis in metastatic melanoma.Asia Pac J Clin Oncol2019
31106127Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort.Transl Lung Cancer Res2019
29350338Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency.J Clin Immunol2018
29350338Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency.J Clin Immunol2018
28823752HER2 testing in advanced gastric and gastro-oesophageal cancer: analysis of an Australia-wide testing program.Pathology2017
28823752HER2 testing in advanced gastric and gastro-oesophageal cancer: analysis of an Australia-wide testing program.Pathology2017
26727910Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals.J Neurovirol2016
27393503Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatment.Lung Cancer2016
26727910Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals.J Neurovirol2016
26422587HER2 expression in oesophageal carcinoma and Barrett's oesophagus associated adenocarcinoma: An Australian study.Eur J Surg Oncol2016
27567228Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program.Pathology2016
26422587HER2 expression in oesophageal carcinoma and Barrett's oesophagus associated adenocarcinoma: An Australian study.Eur J Surg Oncol2016
27567228Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program.Pathology2016
27393503Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatment.Lung Cancer2016
25688309Intraosseous lipomatous meningioma.Case Rep Neurol Med2015
25847523Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing.Histopathology2015
25688309Intraosseous lipomatous meningioma.Case Rep Neurol Med2015
25896973Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial.Clin Cancer Res2015
25896973Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial.Clin Cancer Res2015
25847523Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing.Histopathology2015
24056965c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer.Oncogene2014
25538211Adrenal tumours: how to establish malignancy.BMJ Case Rep2014
24122263Metastatic progression of breast cancer: insights from 50 years of autopsies.J Pathol2014
24056965c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer.Oncogene2014
24673736National Working Group Meeting on ALK diagnostics in lung cancer.Asia Pac J Clin Oncol2014
24842379Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer.Pathology2014
25538211Adrenal tumours: how to establish malignancy.BMJ Case Rep2014
24842379Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer.Pathology2014
24673736National Working Group Meeting on ALK diagnostics in lung cancer.Asia Pac J Clin Oncol2014
24122263Metastatic progression of breast cancer: insights from 50 years of autopsies.J Pathol2014
24004612Clinical and molecular characterization of HER2 amplified-pancreatic cancer.Genome Med2013
24247619Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33.Pathology2013
24004612Clinical and molecular characterization of HER2 amplified-pancreatic cancer.Genome Med2013
24247619Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33.Pathology2013
22385431Myositis due to the microsporidian Anncaliia (Brachiola) algerae in a lung transplant recipient.Transpl Infect Dis2012
22437749Glioblastoma with primitive neuroectodermal tumour-like components.Pathology2012
22385431Myositis due to the microsporidian Anncaliia (Brachiola) algerae in a lung transplant recipient.Transpl Infect Dis2012
22678156Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program.Breast Cancer Res Treat2012
22314190Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophageal junction cancer testing accuracy in Australia.Am J Surg Pathol2012
23176370A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease.BMC Cancer2012
23176370A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease.BMC Cancer2012
22437749Glioblastoma with primitive neuroectodermal tumour-like components.Pathology2012
22678156Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program.Breast Cancer Res Treat2012
22314190Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophageal junction cancer testing accuracy in Australia.Am J Surg Pathol2012
  • 1 - 50 of 142

Recommended Authors

Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 2
Danh Tran-Thanh
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2002
Number of shared co-authors 2
Robin D LeGallo
University of Virginia Department of Pathology
Career Start Year 2001
Number of shared co-authors 3
Marcory C R F van Dijk
1Rijnstate Hospital
Career Start Year 2001
Number of shared co-authors 0
Christopher J Howlett
Western University
Career Start Year 1999
Number of shared co-authors 1
Lawrence J Jennings
Northwestern University Feinberg School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Career Start Year 1995
Number of shared co-authors 9
William J Howat
Cancer Research UK Cambridge Institute
Career Start Year 1994
Number of shared co-authors 4
Michael Bzorek
Zealand University Hospital
Career Start Year 1994
Number of shared co-authors 0
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Weei-Yuarn Huang
Nova Scotia Health Authority
Career Start Year 1992
Number of shared co-authors 1
Gregory J Tsongalis
Dartmouth Health and the Dartmouth Cancer Center, USA Geisel School of Medicine
Career Start Year 1990
Number of shared co-authors 0
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1989
Number of shared co-authors 1
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 8
Cindy L Vnencak-Jones
Vanderbilt University Medical Center
Career Start Year 1987
Number of shared co-authors 0
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Sue Hammond
Flinders University Library, Flinders University
Career Start Year 1985
Number of shared co-authors 2
Ossama Tawfik
University of Kansas
Career Start Year 1985
Number of shared co-authors 0
Rex C Bentley
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 1
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 0
Jos?? Palacios
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 2
Jahn M Nesland
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 3
Fabien Calvo
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 1
Hugh Dawkins
The University of Notre Dame Australia
Career Start Year 1979
Number of shared co-authors 1
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 3
David M Parham
Keck School of Medicine, University of Southern California
Career Start Year 1977
Number of shared co-authors 2
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0
Timothy J Triche
Center for Epigenetics, Van Andel Research Institute
Career Start Year 1971
Number of shared co-authors 2
Jack L Pinkus
Brigham and Women's Hospital Department of Neurology, and Harvard Medical School
Career Start Year 1965
Number of shared co-authors 0

Collaborators

Sunil R Lakhani
University of Queensland
Co-authored papers 3
Robyn L Ward
University of Sydney
Co-authored papers 3
Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 3
Nicholas J Hawkins
School of Public Health, Imperial College London
Co-authored papers 3
Christine L Clarke
Westmead Institute for Medical Research, University of Sydney
Co-authored papers 2
Thomas John
Peter MacCallum Cancer Centre
Co-authored papers 2
Lucy R Webster
Sydney West Area Health Service
Co-authored papers 2
Amber L Johns
Garvan Institute of Medical Research and The Kinghorn Cancer Centre
Co-authored papers 2
Karen Byth
Westmead Hospital
Co-authored papers 2
Pamela J Provan
Westmead Institute for Medical Research, Westmead Hospital, The University of Sydney
Co-authored papers 2
Paul Mitchell
Olivia Newton-John Cancer Research Institute
Co-authored papers 2
Sean M Grimmond
The University of Melbourne
Co-authored papers 2
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Co-authored papers 2
Puey Ling Chia
Lee Kong Chian School of Medicine, Nanyang Technological University
Co-authored papers 1
Elizabeth L Salisbury
Prince of Wales Hospital
Co-authored papers 1
Katia Nones
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Maud H W Starmans
Ontario Institute for Cancer Research
Co-authored papers 1
Nicola Waddell
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Khashayer Asadi
Co-authored papers 1
Marzena Walkiewicz
Olivia Newton-John Cancer Research Institute
Co-authored papers 1
Simon Knight
Churchill Hospital
Co-authored papers 1
Herbert Herzog
Garvan Institute of Medical Research
Co-authored papers 1
Gareth Rivalland
Auckland City Hospital
Co-authored papers 1
Jerry Usary
Co-authored papers 1
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 1
Yen Tran
University of California Davis
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
David A Cooper
Co-authored papers 1
David M Thomas
Garvan Institute of Medical Research
Co-authored papers 1
Release 1.2